title: Efficacy of ruxolitinib in chronic eosinophilic leukemia associated with a PCM1-JAK2 fusion gene.
authors: Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Viale Golgi 19, 27100 Pavia, Italy. elisarumi@hotmail.com
authors: Elisa
authors: E
authors: Rumi
authors: Jelena D
authors: JD
authors: Milosevic
authors: Ilaria
authors: I
authors: Casetti
authors: Irene
authors: I
authors: Dambruoso
authors: Daniela
authors: D
authors: Pietra
authors: Emanuela
authors: E
authors: Boveri
authors: Marina
authors: M
authors: Boni
authors: Paolo
authors: P
authors: Bernasconi
authors: Francesco
authors: F
authors: Passamonti
authors: Robert
authors: R
authors: Kralovics
authors: Mario
authors: M
authors: Cazzola
mesh_terms: D000328:Adult; D002471:Cell Transformation, Neoplastic / Q000187:drug effects* / Q000473:pathology; D002908:Chronic Disease; D005260:Female; D015321:Gene Rearrangement; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000188:drug therapy* / Q000235:genetics; D053612:Janus Kinases / Q000037:antagonists & inhibitors; D009570:Nitriles; D015514:Oncogene Proteins, Fusion / Q000235:genetics* / Q000378:metabolism; D011720:Pyrazoles / Q000008:administration & dosage*; D011743:Pyrimidines; D012074:Remission Induction; D014178:Translocation, Genetic
chemical_list: D009570:Nitriles; D015514:Oncogene Proteins, Fusion; C575876:PCM1-JAK2 fusion protein, human; D011720:Pyrazoles; D011743:Pyrimidines; C540383:ruxolitinib; D053612:Janus Kinases